A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes

Tissue Antigens

Volumn 60, Issue 5, 2002, Pages 365-371

  Zhang, Y ^a   Stroobant, V ^a   Russo, V ^b   Boon, T ^a   Van der Bruggen, Pierre ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antigenic peptide; CTL; HLA B37; MAGE A4; Tumor

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; HLA B ANTIGEN; HLA B37 ANTIGEN; HLA B3701 ANTIGEN; MELANOMA ANTIGEN 4; PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ESOPHAGUS CARCINOMA; GENE EXPRESSION; GENETIC TRANSFECTION; GERM LINE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LUNG CARCINOMA; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN PROCESSING; SEQUENCE ANALYSIS; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CELLS, CULTURED; DENDRITIC CELLS; HLA-B ANTIGENS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036866064     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.600503.x     Document Type: Article

References (27)

1. De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994: 40: 360-9.
2. Lurquin C, De Smet C, Brasseur F et al. Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins. Genomics 1997: 46: 397-408.
3. Lucas S, De Smet C, Arden KC et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998: 58: 743-52.
4. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001: 61: 5544-51.
5. Haas GG Jr, D'Cruz OJ, De Bault LE. Distribution of human leukocyte antigen-ABC and - D/DR antigens in the unfixed human testis. Am J Reprod Immunol Microbiol 1988: 18: 47-51.
6. Hunt DF, Henderson RA, Shabanowitz J et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992: 255: 1261-3.
7. Marchand M, Brichard V, van Baren N, Coulie PG. Biological and clinical developments in melanoma vaccines. Exp Opin Biol Ther 2001: 1: 497-510.
8. Jäger E, Jäger D, Knuth A. Clinical cancer vaccine trials. Curr Opin Immunol 2002: 14: 178-82.
9. Marchand M, van Baren N, Weynants P et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999: 80: 219-30.
10. Thurner B, Haendle I, Roder C et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999: 190: 1669-78.
11. De Plaen E, Naerhuyzen B, De Smet C, Szikora J-P, Boon T. Alternative promoters of gene MAGE4a. Genomics 1997: 40: 305-13.
12. Duffour M-T, Chaux P, Lurquin C, Cornelis G, Boon T, van der Bruggen P. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes. Eur J Immunol 1999: 29: 3329-37.
13. Traversari C, van der Bruggen P, Van den Eynde B et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992: 35: 145-52.
14. Van Snick J, Vink A, Cayphas S, Uyttenhove C. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmocytomas. J Exp Med 1987: 165: 641-9.
15. Mavilio F, Ferrari G, Rossini S et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994: 83: 1988-97.
16. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 1986: 95: 99-105.
17. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Meth 1989: 119: 203-10.
18. Chaux P, Luiten R, Demotte N et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with. MAGE-A1 J Immunol 1999: 163: 2928-36.
19. Rammensee H-G, Bachmann J, Stevanovic S. MHC Ligands and Peptide Motifs. New York: Springer, 1997.
20. Falk K, Rötzschke O, Grahovac B et al. Peptide motifs of HLA-B35 and - B37 molecules. Immunogenetics 1993: 38: 161-2.
21. Schultz ES, Zhang Y, Knowles R et al. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens 2001: 57: 103-9.
22. Luiten R, van der Bruggen P. A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes. Tissue Antigens 2000: 55: 149-52.
23. Traversari C, van der Bruggen P, Luescher IF et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992: 176: 1453-7.
24. van der Bruggen P, Szikora J-P, Boël P et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA.Cw*1601. Eur J Immunol 1994; 24: 2134-40.
25. van der Bruggen P, Zhang Y, Chaux P et al. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev, in. press.
26. Chen CH, Huang GT, Lee HS et al. High frequency of expression of MAGE genes in human hepatocellular carcinoma. Liver 1999: 19: 110-4.
27. Dalerba P, Frascella E, Macino B et al. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas. Int J Cancer 2001: 93: 85-90.